Testing effectiveness (Phase 2)UnknownNCT00003827What this trial is testingCombination Chemotherapy in Treating Patients With Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes ALZA 25
Not applicableStudy completedNCT03490747What this trial is testingEvaluation of a Physical Activity Referral SchemeWho this might be right forCardiovascular Risk FactorDiabetes Mellitus, Type 2Anxiety+7 more Paula Watson 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262843What this trial is testingTotal Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+1 more City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00903760What this trial is testingDecitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)Who this might be right forMyelodysplastic Syndrome M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT01522976What this trial is testingAzacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaWho this might be right forChronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia-1Chronic Myelomonocytic Leukemia-2+4 more National Cancer Institute (NCI) 282
Early research (Phase 1)UnknownNCT05457010What this trial is testingPhase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDSWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndromes Arcellx, Inc. 24
Early research (Phase 1)Study completedNCT01139151What this trial is testing4'-Thio-araC (Thiarabine) in Advanced Hematologic MalignanciesWho this might be right forLeukemia M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT00846430What this trial is testingMedical Treatment of "High-Risk" NeurofibromasWho this might be right forNeurofibromatosis 1 Corewell Health West 9
Not applicableStudy completedNCT02113865What this trial is testingScore System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV PatientsWho this might be right forAcquired Immunodeficiency Syndrome VirusHepatitis, Viral, Non-A, Non-B, Parenterally-TransmittedHepatocellular Carcinoma Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 45
Testing effectiveness (Phase 2)Ended earlyNCT01465386What this trial is testingBortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in RemissionWho this might be right forAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Myeloblastic Leukemia Without Maturation (M1)+9 more Fred Hutchinson Cancer Center 6
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Early research (Phase 1)Ended earlyNCT02319369What this trial is testingSafety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)Who this might be right forAcute Myelogenous LeukemiaMyelodysplastic Syndrome Daiichi Sankyo 74
Testing effectiveness (Phase 2)Study completedNCT02046122What this trial is testingAdoptive Transfer of Haplo-identical DLI for AML and MDSWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome Duke University 19
Not applicableLooking for participantsNCT07498829What this trial is testingPopulation Based Germline Testing for Early Detection and Prevention of CancerWho this might be right forBreast Cancer RiskOvarian Cancer RiskCancer Gene Mutation Queen Mary University of London 6,000
Very early researchUnknownNCT01574261What this trial is testingCould the Therapy With Inositol Affect the Cardiovascular Risk in PCOS Women? Results of a Randomized Clinical TrialWho this might be right forPolycystic Ovary Syndrome Catholic University of the Sacred Heart 70
Testing effectiveness (Phase 2)Study completedNCT00335556What this trial is testingCombination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney TumorsWho this might be right forChildhood Renal Cell CarcinomaClear Cell Renal Cell CarcinomaClear Cell Sarcoma of the Kidney+10 more Children's Oncology Group 291
Testing effectiveness (Phase 2)Study completedNCT02169791What this trial is testingNonmyeloablative Haploidentical Transplant Followed by MLN9708Who this might be right forAcute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more Northside Hospital, Inc. 29
Not applicableEnded earlyNCT04668521What this trial is testingMultifactorial Risk Assessment for Breast & Ovarian Cancer Risk DetectionWho this might be right forAdnexal MassGermline BRCA1 Gene MutationGermline BRCA2 Gene Mutation+1 more Aspira Women's Health 215
Testing effectiveness (Phase 2)Study completedNCT01869114What this trial is testingSirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive ChemotherapyWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 57
Testing effectiveness (Phase 2)Study completedNCT00083187What this trial is testingVNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk MyelodysplasiaWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Vion Pharmaceuticals 230